Clinical Trial Update: Treatment of Subarachnoid Hemorrhage With Human Albumin [Phase 1]

View source ↗

Summary

This clinical trial update reports that the Phase 1 study of treating Subarachnoid Hemorrhage with human albumin has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage

Drugs mentioned

• Human Serum Albumin (human serum albumin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Subarachnoid Hemorrhage | Phase 1 | Status: TERMINATED